"Immunoprecipitation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The aggregation of soluble ANTIGENS with ANTIBODIES, alone or with antibody binding factors such as ANTI-ANTIBODIES or STAPHYLOCOCCAL PROTEIN A, into complexes large enough to fall out of solution.
| Descriptor ID |
D047468
|
| MeSH Number(s) |
E05.196.150.639 E05.478.605
|
| Concept/Terms |
Immunoprecipitation- Immunoprecipitation
- Immune Precipitation
- Immune Precipitations
- Precipitation, Immune
- Precipitations, Immune
|
Below are MeSH descriptors whose meaning is more general than "Immunoprecipitation".
Below are MeSH descriptors whose meaning is more specific than "Immunoprecipitation".
This graph shows the total number of publications written about "Immunoprecipitation" by people in this website by year, and whether "Immunoprecipitation" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 0 | 1 | 1 |
| 2011 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Immunoprecipitation" by people in Profiles.
-
Altered NEP2 expression and activity in mild cognitive impairment and Alzheimer's disease. J Alzheimers Dis. 2012; 28(2):433-41.
-
Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat Med. 2011 Jul 31; 17(8):952-60.
-
Effect of poly(ADP-ribose) polymerase 1 on integration of the adeno-associated viral vector genome. J Gene Med. 2011 Jun; 13(6):342-52.
-
Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis. Sci Transl Med. 2011 Jun 01; 3(85):85ra46.
-
Differential localization of neuregulin-1 type III in the central and peripheral nervous system. Brain Res. 2011 Jan 19; 1369:10-20.
-
Vitamin C downregulates interleukin-18 production by increasing reactive oxygen intermediate and mitogen-activated protein kinase signalling in B16F10 murine melanoma cells. Melanoma Res. 2003 Dec; 13(6):549-54.